Clinical trial
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
NCT00532922 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- November 30, 2007
- Enrollment
- 310 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.